Liver cancer showdown: which combo causes less harm?
NCT ID NCT07277192
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 562 people with advanced liver cancer to compare two treatment combinations: one using HAIC (chemotherapy directly into the liver) plus immunotherapy and targeted drugs, and the other using TACE (a procedure that blocks blood flow to the tumor) plus the same drugs. The main goal was to see which approach caused less liver injury and helped patients live longer. Results help doctors choose the safer, more effective option for managing this serious disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanfang Hospital of Southern Medical University
Guangzhou, Guangdong, 510515, China